Specific crRNA and system for ASFV detection based on ERA coupled CRISPR / Cas12a
Through the ERA-coupled CRISPR/Cas12a system combined with enzymatic recombination technology, the equipment dependence and false positive problems of ASFV detection are solved, and fast, sensitive and specific detection is achieved. It is suitable for grassroots places and improves the accuracy and reliability of the detection. sex.
Patent Information
- Application Number
- CN202411240546.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-05
- Publication Date
- 2024-11-15
AI Technical Summary
The existing African swine fever virus (ASFV) detection methods are complicated to operate, strong equipment dependence, insufficient sensitivity and false positive risks, making it difficult to meet the needs of speed, accuracy and cost-effectiveness.
Using specific crRNA and system based on ERA-coupled CRISPR/Cas12a, combined with enzymatic recombinant isothermal amplification technology and CRISPR/Cas12a system, the Cas12a enzyme is activated through isothermal amplification and crRNA recognition to achieve efficient and specific detection of ASFV. The fluorescent or colloidal gold signal was visualized and read out.
It realizes rapid, sensitive and specific detection of ASFV, reduces the complexity of the detection process and equipment dependence, and is suitable for grassroots farms that lack laboratory facilities, improving the accuracy and reliability of diagnosis.
Smart Images

Figure CN118957153A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of molecular biology detection technology, and in particular to a specific crRNA and system for ASFV detection based on ERA-coupled CRISPR / Cas12a. Background Art
[0002] African swine fever (ASF) caused by African swine fever virus (ASFV) is an acute, highly contagious febrile disease of pigs. This disease is highly contagious and has a high mortality rate, causing serious economic losses to the global pig farming industry. Due to the complex immune evasion mechanism and rich genetic diversity of ASFV, there is currently no effective vaccine available for immune prevention despite continuous in-depth research. These factors make the prevention and control of the disease a huge challenge. Therefore, the development of early, accurate and rapid diagnostic technology for ASFV is particularly important for its biological prevention and control. In the field of public health and disease prevention, molecular detection technology has played a key role. In recent years, the outbreak of African swine fever has brought unprecedented challenges to traditional molecular detection methods due to its enhanced transmissibility and more hidden nature. Traditional detection technologies, including fluorescent quantitative PCR and LAMP, have inherent limitations. For example, fluorescent quantification and sequencing technologies require complex equipment and skilled operators; while LAMP is prone to nonspecific amplification, which may lead to false positive results.
[0003] In this regard, the use of nucleic acid detection methods can improve the specificity of detection. However, although the existing conventional nucleic acid detection methods are sensitive and specific, the detection process is complicated and requires expensive instruments and equipment, which makes disease detection more difficult. Summary of the invention
[0004] In view of the above-mentioned prior art, the purpose of the present invention is to provide a rapid, sensitive, specific and cost-effective ASFV detection specific crRNA and system based on ERA-coupled CRISPR / Cas12a to address the shortcomings of the ASFV detection method in the prior art.
[0005] In order to achieve the above-mentioned object, the present invention provides a specific crRNA for ASFV detection based on ERA-coupled CRISPR / Cas12a, and the specific crRNA for ASFV detection is shown in one or more of SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3, SEQ ID No: 4, SEQ ID No: 5 and SEQ ID No: 6.
[0006] Preferably, the specific crRNA for ASFV detection is shown in one or more of SEQ ID No: 2, SEQ ID No: 4 and SEQ ID No: 5.
[0007] The present invention also provides an ASFV detection system based on ERA-coupled CRISPR / Cas12a, characterized in that the ASFV detection system comprises at least the specific crRNA for ASFV detection as described above, an isothermal amplification primer pair matched with the specific crRNA for amplifying the template to be tested, and a ssDNA reporter system.
[0008] Preferably, the isothermal amplification primer pair is selected from one or more of a first primer pair as shown in SEQ ID No:7 and SEQ ID No:8, a second primer pair as shown in SEQ ID No:9 and SEQ ID No:10, a third primer pair as shown in SEQ ID No:11 and SEQ ID No:12, a fourth primer pair as shown in SEQ ID No:13 and SEQ ID No:14, a fifth primer pair as shown in SEQ ID No:15 and SEQ ID No:16, and a sixth primer pair as shown in SEQ ID No:17 and SEQ ID No:18.
[0009] Preferably, when containing crRNA as shown in SEQ ID No: 1 and / or SEQ ID No: 2, the first primer pair and / or the second primer pair are used;
[0010] When containing crRNA as shown in SEQ ID No: 3 and / or SEQ ID No: 4, a third primer pair and / or a fourth primer pair are used;
[0011] When containing crRNA as shown in SEQ ID No: 5 and / or SEQ ID No: 6, the fifth primer pair and / or the sixth primer pair are used.
[0012] Preferably, the isothermal amplification primer pair is selected from one or more of the second primer pair, the fourth primer pair and the fifth primer pair.
[0013] Preferably, the ssDNA reporter system comprises a first ssDNA reporter molecule for fluorescence detection, and / or a second ssDNA reporter molecule for colloidal gold detection.
[0014] Preferably, the nucleotide sequence of the first ssDNA reporter molecule is: 5'-TTTTTTTT-3', and the nucleotide sequence of the second ssDNA reporter molecule is: 5'-TTTATTT-3'.
[0015] Preferably, the 5' end of the first ssDNA reporter molecule is modified with a FAM group, and the 3' end is modified with a BHQ1 group;
[0016] The 5' end of the second ssDNA reporter molecule is modified with a FAM group, and the 3' end is modified with a Biotin group.
[0017] Preferably, the ASFV detection system also includes enzymes and buffers required for the ERA process, and Cas12a enzymes required for the CRISPR / Cas12a system.
[0018] The present invention also provides a use of the specific crRNA for ASFV detection described above, or the ASFV detection system described above in the preparation of an ASFV detection kit.
[0019] The present invention also provides a method for detecting ASFV for non-disease diagnosis purposes, and the detection method adopts the ASFV detection system described above.
[0020] Preferably, the detection method comprises:
[0021] S100, releasing the nucleic acid in the sample to be tested to obtain a test template, and using isothermal amplification primers to specifically amplify the test template to obtain an amplification product;
[0022] S200, activating the non-specific single-stranded DNA cleavage activity of the Cas12a enzyme by binding crRNA to the specific gene sequence in the amplified product of step S100;
[0023] S300, based on the ssDNA reporter system, determine whether the template to be tested contains ASFV by detecting the reporter signal.
[0024] Through the above technical scheme, the present invention proposes an ASFV efficient diagnostic system combining enzymatic recombinant isothermal amplification technology (ERA) and CRISPR / Cas12a technology. The core of the system lies in two steps: first, the enzymatic recombinant isothermal amplification method is used to efficiently amplify a specific nucleic acid sequence to achieve preliminary detection; secondly, the CRISPR / Cas12a protein is used to identify and detect specific target sequences in the amplified product to complete accurate detection. This technology uses a constant temperature reaction, has the advantages of high efficiency, simple operation, and low instrument requirements, and quickly determines the target sequence by detecting the presence or absence of the amplified product. Then, the activity of the enzyme is triggered by introducing the probe into the CRISPR / Cas12a system and the crRNA specifically recognizes the target gene sequence, and a specific light source or colloidal gold test strip is used to achieve visual detection of ASFV.
[0025] Compared with traditional pathogen detection methods such as RT-qPCR, serological testing and test strips, the technical solution of the present invention overcomes the limitations of cumbersome operation, long reaction time, high equipment dependence and insufficient sensitivity. Although the current method uses enzymatic recombinant isothermal amplification for pathogen detection, there are concerns about accuracy because there is only a single detection step. The present invention combines enzymatic recombinant isothermal amplification with Cas12a protein to not only achieve high sensitivity and high specificity detection of ASFV, but also further improve the diagnostic accuracy, and the detection process is simple, rapid and does not require high-end equipment. This technology is particularly suitable for grassroots breeding sites that lack laboratory facilities and untrained personnel. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] The accompanying drawings are used to provide a further understanding of the present invention and constitute a part of the specification. Together with the following specific embodiments, they are used to explain the present invention but do not constitute a limitation of the present invention. In the accompanying drawings:
[0027] Figure 1 This is a schematic diagram of the principle of the present invention based on ERA-coupled CRISPR / Cas12a detection;
[0028] Figure 2 This is a schematic diagram of the fluorescence signal of the ASFV three-gene crRNA screening results based on CRISPR / Cas12a in Preparation Example 2 of the present invention;
[0029] Figure 3 This is a fluorescence display result diagram of the sensitivity and specificity of the African swine fever virus ERA coupled CRISPR / Cas12a method in Verification Example 1 of the present invention for detecting the three genes of ASFV. Figure 3 A- Figure 3 C corresponds to the E183L, K205R, and C962R gene detection methods at different concentrations (the concentrations corresponding to the 8 bands in each figure are 1×10 6 copies / μL, 1×10 5 copies / μL, 1×10 4 copies / μL, 1×10 3 copies / μL, 1×10 2 copies / μL, 1×10 1 copies / μL, 1×10 0 copies / μL, negative control); Figure 3 D- Figure 3 F corresponds to the specificity of the detection method for E183L, K205R, and C962R genes, respectively (the eight bands in each figure are positive control, PRV, PPV, PEDV, CSFV, PCV-2, PRRSV, and negative control from left to right);
[0030] Figure 4 This is a colloidal gold test strip showing the sensitivity and specificity of the African swine fever virus ERA coupled CRISPR / Cas12a method for detecting the three genes of ASFV in Verification Example 2 of the present invention. Figure 4 A- Figure 4 C corresponds to the E183L, K205R, and C962R gene detection methods at different concentrations (the concentrations corresponding to the 8 bands in each figure are 1×10 6 copies / μL, 1×10 5 copies / μL, 1×10 4 copies / μL, 1×10 3 copies / μL, 1×10 2 copies / μL, 1×10 1 copies / μL, 1×10 0 copies / μL, negative control); Figure 4 D- Figure 4 F corresponds to the specificity of the detection method for E183L, K205R, and C962R genes, respectively (the 7 bands in each figure are positive control, PRV, PPV, PEDV, CSFV, PCV-2, and PRRSV from left to right); DETAILED DESCRIPTION
[0031] The specific embodiments of the present invention are described in detail below. It should be understood that the specific embodiments described herein are only used to illustrate and explain the present invention, and are not used to limit the present invention.
[0032] Specifically, the present invention provides an African swine fever virus detection system based on ERA coupled to CRISPR / Cas12a. The African swine fever virus detection system selectively includes a first detection system for the African swine fever virus E183L gene, and / or a second detection system for the African swine fever virus K205R gene, and / or a third detection system for the African swine fever virus C962R gene. The detection principle is as follows Figure 1 shown.
[0033] Further, each specific detection system includes a specific constant temperature amplification primer pair, a specific crRNA, a CRISPR / Cas12a protein and a detection probe. The above-mentioned specific constant temperature amplification primer pair and specific crRNA need to be adapted to the corresponding target gene. Specifically, for the E183L gene, the crRNA as shown in SEQ ID No: 1 and / or SEQ ID No: 2, and the first primer pair as shown in SEQ ID No: 7 and SEQ ID No: 8 and / or the second primer pair as shown in SEQ ID No: 9 and SEQ ID No: 10 are used, and more preferably, the crRNA and the second primer pair as shown in SEQ ID No: 2 are used here; for the K205R gene, the crRNA as shown in SEQ ID No: 3 and / or SEQ ID No: 4, and the third primer pair as shown in SEQ ID No: 11 and SEQ ID No: 12 and / or the fourth primer pair as shown in SEQ ID No: 13 and SEQ ID No: 14 are used, and more preferably, the crRNA and the fourth primer pair as shown in SEQ ID No: 4 are used here; for the C962R gene, the crRNA as shown in SEQ ID No: 5 and / or SEQ ID No: 6, and the fifth primer pair as shown in SEQ ID No: 15 and SEQ ID No: 16 and / or the fifth primer pair as shown in SEQ ID No: 17 and SEQ ID No: 18 are used. The sixth primer pair shown in No: 18, more preferably, the crRNA and the fifth primer pair shown in SEQ ID No: 5 are selected here.
[0034] The detection probe may specifically be a first probe having a nucleotide sequence of 5′FAM-TTTTTTTT-BHQ13′, and / or a second probe having a nucleotide sequence of 5′FAM-TTTTATTT-Biotin 3′.
[0035] The African swine fever virus detection system can be divided into an ERA constant temperature amplification system and a CRISPR / Cas12a detection system. Furthermore, the ERA constant temperature amplification system also includes Rehydration Buffer, RNase Inhibitor, template RNA, RNase free water and magnesium acetate; the CRISPR / Cas12a detection system also includes RNase Inhibitor, ERAA amplification product and RNase free water.
[0036] More specifically, the present invention also provides an African swine fever virus nucleic acid detection kit based on the above detection system.
[0037] The African swine fever virus nucleic acid detection kit includes an equal volume of ERA constant temperature amplification system and CRISPR / Cas12a detection system; each 50μL ERA constant temperature amplification system includes: 20μL of dissolving agent, 2.5μL of 10μM forward primer, 2.5μL of 10μM reverse primer, 13μL of RNase free water, and 2μL of activator; each 30μL CRISPR / Cas12a detection system includes: 3μL of 10×Buffer, 1μL of LbCas12a, 2μL of crRNA, 6μL of ssDNA fluorescent probe, 10μL of EPA amplification product, and 8μL of RNasefree water. It should be noted that the dosage of each of the above-mentioned reaction reagents can be further adjusted by a technician in this field according to actual operation. The present invention is not limited to this specific dosage. The specific dosage here only refers to the actual dosage in the specific experiment of the present invention.
[0038] The specific operation is as follows:
[0039] a) Add the sample to be tested into the lysate, mix vigorously for 5-10 seconds at room temperature, let stand for 1-3 minutes, and take the supernatant to complete the preparation of the template;
[0040] b) using enzymatic recombination isothermal amplification reaction technology to specifically amplify the ASFV SEQ ID NO.10 (E183L), SEQ ID NO.11 (K205R) and SEQ ID NO.12 (C962R) gene sequences;
[0041] c) Using the CRISPR / Cas12a system, the crRNA binds to the ASFV-specific gene sequence in the amplified product to activate the non-specific single-stranded DNA cleavage activity of the Cas12a enzyme;
[0042] d) Based on the first ssDNA reporter molecule for fluorescence detection, the single-stranded DNA probe with a fluorescent label is cut by the Cas12a enzyme to generate a fluorescent signal, and the presence or absence of the fluorescent signal is detected to determine whether the sample contains ASFV; and / or, using the second ssDNA reporter molecule for colloidal gold detection, the colloidal gold rapid diagnostic test strip technology is used to determine whether the sample contains ASFV.
[0043] Among them, if the first ssDNA reporter molecule is used for detection, the reaction tube is placed under blue light, and green fluorescence appears, which means that the African swine fever is positive; if the second ssDNA reporter molecule is used for detection, after incubation with the colloidal gold test strip, the test strip shows a positive African swine fever.
[0044] The following is a detailed description in conjunction with a specific embodiment. In the present invention, the crRNA and probes here are synthesized and provided by Guangzhou Aidi Gene Technology Co., Ltd., and primers and standard plasmids are synthesized and provided by GENEWIZ (Jin Weizhi) Biotechnology Co., Ltd. The viral genomic DNA used is to be stored in the laboratory for standby after extracting the commercially available attenuated or inactivated vaccine nucleic acid of the corresponding virus using a nucleic acid extraction kit, specifically, pseudorabies live vaccine (Bartha-K61 strain) is derived from the commercially available product of China Animal Husbandry Co., Ltd., and the bivalent live vaccine of porcine transmissible gastroenteritis and porcine epidemic diarrhea is derived from the commercially available product of Wuhan Keqian Biological Co., Ltd., Lanjie porcine reproductive and respiratory syndrome live vaccine (R98 strain) is derived from the commercially available product of China Animal Husbandry Co., Ltd., Kexining porcine parvovirus inactivated vaccine is derived from the commercially available product of Wuhan Keqian Biological Co., Ltd., Kewening swine fever live vaccine (cell source) is derived from the commercially available product of Wuhan Keqian Biological Co., Ltd., and Keyuanning porcine circovirus type 2 inactivated vaccine is derived from the commercially available product of Wuhan Keqian Biological Co., Ltd.
[0045] Reagents: LbCas12a (Guangzhou Aidi Gene Technology Co., Ltd., catalog number EDE0005-2000), basic nucleic acid amplification kit (ERA method) (Suzhou Xinda Gene Technology Co., Ltd., catalog number KS101), plasmid extraction kit (Tiangen Biochemical Technology (Beijing) Co., Ltd., catalog number DP103), enzyme-free sterile water (Beijing Solebold Technology Co., Ltd., catalog number R1600).
[0046] Preparation Example 1: Enzymatic Recombinant Isothermal Amplification (ERA) and Primer Screening
[0047] The technical solution of the present invention designs corresponding ERA primers (SEQ ID No: 7 to SEQ ID No: 18) for the conservative gene sequence fragments of African swine fever virus (E183L, K205R, C962R), and two sets of primer pairs are designed for each gene. The details are shown in Table 1.
[0048] On this basis, after ERA amplification using the above primer pairs, the CRISPR / Cas12a detection system was performed to determine the primer pairs with the best amplification effect: E183L-forword-2 and E183L-reverse-2; K205R-forword-2 and K205R-reverse-2; C962R-forword-1 and C962R-reverse-1.
[0049] Table 1
[0050]
[0051]
[0052] Preparation Example 2: Enzymatic Recombination Isothermal Amplification Reaction and Screening of crRNA
[0053] Based on the ERA-CRISPR / Cas12a system, crRNAs as shown in SEQ ID No: 1 to SEQ ID No: 6 were designed. Specifically, as shown in Table 2. Among them, SEQ ID No: 1 and SEQ ID No: 2 are crRNAs corresponding to the E183L gene, SEQ ID No: 3 and SEQ ID No: 4 are crRNAs corresponding to the K205 gene, and SEQ ID No: 5 and SEQ ID No: 6 are crRNAs corresponding to the C962R gene.
[0054] ASFV plasmid DNA and negative control were used as templates. ABIQuantStudio 5 and blue light were used to determine the test results. When the same amount of DNA and different primers were used, the effectiveness of the above crRNAs for visible fluorescence detection was tested. The results are shown in Figure 2. Figure 2 shown.
[0055] pass Figure 2 It can be seen that E183L-crRNA-B, K205R-crRNA-B and C962R-crRNA-A have good targeting and show high detection fluorescence intensity, that is, the efficiency of the CRISPR / Cas12a cross-cleavage system induced by E183L-crRNA-2 is higher than that of E183L-crRNA-1, K205R-crRNA-2 is higher than that of K205R-crRNA-1, and C962R-crRNA-1 is higher than that of C962R-crRNA-2. It is concluded that E183L-crRNA-2, K205R-crRNA-2, and C962R-crRNA-1 have the best amplification effect.
[0056] Table 2
[0057]
[0058] Preparation Example 3: Preparation of standard plasmids of African swine fever virus E183L gene, K205R gene and C962R gene
[0059] According to the E183L gene, K205R gene and C962R gene sequences of the African swine fever virus type I Chinese epidemic strain Pig / SD / DY-I / 2021 recorded in GenBank, artificial synthesis was performed to obtain the corresponding synthetic fragments SEQ ID No: 19, SEQ ID No: 20, SEQ ID No: 21; with the help of recombinant DNA technology, the synthetic fragments were each connected to the pUC57 cloning vector in a 1:1 ratio to construct a recombinant plasmid; after the obtained recombinant plasmid was transformed into DH5α competent cells, the transformed competent cells were cultured, and after a single colony grew out, the single bacteria were picked out for amplification and then extracted to obtain a positive control plasmid, and the extracted plasmid concentration was measured by an ultramicro spectrophotometer, and the copy number was calculated.
[0060] Example 1: Construction of African swine fever virus detection system based on ERA coupled CRISPR / Cas12a
[0061] 1. Viral nucleic acid extraction: Use the African swine fever virus DNA extraction kit to extract viral nucleic acid according to the following steps: (1) Centrifuge the test sample at 12000r / min for 5 minutes to extract the supernatant; (2) Add swine fever virus lysis solution to the supernatant, mix well and place at room temperature for 5 minutes; (3) Add an appropriate amount of protein removal solution, mix well and place in a centrifuge for 5 minutes; (4) Place the supernatant in an EP tube and add a mixed solution of isopropanol and glacial acetic acid to mix well. (5) Assemble the column and the collection tube together, add the column to the mixed solution, centrifuge for 1 min or filter the liquid; (6) Add washing solution to the column, let it stand for 1 min, and then filter the liquid; (7) Add desalted solution to the column and centrifuge for 1 min; (8) Place the column in an EP tube and add elution solution to the center of the column filter membrane. After 1 min, centrifuge to obtain the nucleic acid solution. If you want to increase the solution concentration, you can elute it again. Store the obtained DNA gene at -20℃ and the RNA at -80℃.
[0062] 2. Selection of optimal temperature and time: In order to find the optimal reaction temperature and time for African swine fever, the selected plasmid is used as a template and reacted at different water bath temperatures for 30 minutes to amplify the target fragment. Then the standard plasmid is placed in the most appropriate temperature environment. The reaction time is 5 to 40 minutes. A sample is obtained every 5 minutes. The most suitable reaction time is determined based on the amplification effect, thus forming the African swine fever virus EPA detection method.
[0063] 3. Target nucleic acid EPA amplification
[0064] Add the sample DNA (10 μL) in step 1 to the ERA amplification system, and amplify the E183L gene, K205R gene and C962R gene in different reactions (the ERA system consists of the following components: 20 μL of solvent; forward primer: concentration 10 μM, volume 2.5 μL; reverse primer: concentration 10 μM, volume 2.5 μL; 13 μL of nuclease-free water, 10 μL of template DNA and 2 μL of activator), and place at 37°C for 30 min). Among them, here, according to the corresponding target gene, the corresponding primer pair is used. For example, if the E183L gene needs to be amplified, the first primer pair as shown in SEQ ID No: 7 and SEQ ID No: 8 or the second primer pair as shown in SEQ ID No: 9 and SEQ ID No: 10 (preferably the second primer pair) is used; if the K205R gene needs to be amplified, the third primer pair as shown in SEQ ID No: 11 and SEQ ID No: 12 or the fourth primer pair as shown in SEQ ID No: 13 and SEQ ID No: 14 (preferably the fourth primer pair) is used; if the C962R gene needs to be amplified, the fifth primer pair as shown in SEQ ID No: 15 and SEQ ID No: 16 or the sixth primer pair as shown in SEQ ID No: 17 and SEQ ID No: 18 (preferably the fifth primer pair) is used.
[0065] 4. The ERA amplification products (10 μL) of the E183L gene, K205R gene and C962R gene obtained in step 2 were added to the CRISPR / Cas12a detection system (reaction buffer 3 μL; LbCas12a protein 1 μL; 250 nM crRNA 2 μL; 200 nM ssDNA fluorescent reporter molecule (5′FAM-TTTTTTTT-BHQ13′) 6 μL, or 200 nM ssDNA colloidal gold reporter molecule (5′FAM-TTTATTT-Biotin3′) 6 μL; ERA amplification product 10 μL; ddH2O 8 μL, mixed well and placed at 37 ° C for 30 h.
[0066] The immunocolloidal gold test strips mainly include: sample pad, conjugate pad, test line, control line, NC membrane and absorbent pad. The test strips used in this experiment were purchased from Suzhou Xianda Gene Technology Co., Ltd.
[0067] Verification Example 1, CRISPR-Cas12a fluorescence detection of ASFV gene sensitivity and specificity test The CRISPR-Cas12a fluorescence detection process constructed based on Example 1 is as follows:
[0068] For the three genes E183L, K205R, and C962R of African swine fever virus, the ERA method was used for amplification. The detailed configuration of the ERA nucleic acid amplification kit and amplification system used is shown in Table 3. The specific steps of the amplification process are as follows:
[0069] (1) All primers used for ERA amplification were prepared at a working concentration of 10 μM using TE solution.
[0070] (2) Prepare the ERA amplification reaction system according to the following guidelines. After preparation, vortex thoroughly and centrifuge briefly to ensure uniform mixing.
[0071] (3) Add 2 μL of activator to the lid of each reaction tube, then carefully seal it and centrifuge briefly to promote uniform mixing of the activator and reaction mixture.
[0072] (4) Place the reaction tube in a 37°C water bath and incubate for 20 minutes.
[0073] (5) After the incubation is completed, remove the reaction tube for subsequent experimental steps.
[0074] Table 3
[0075] Components Volume / μL Dissolving agent 20 Forward Primer 2.5 Reverse primer 2.5 DNA 10 <![CDATA[H2O]]> 13 Activator 2 Total volume 50
[0076] The product obtained by the above ERA amplification is introduced into the Cas12a reaction system (as shown in Table 4), which includes LbCas12a protein, buffer, crRNA, ssDNA probe and deionized water (ddH2O). In order to verify the cleavage activity of Cas12a, an experimental group and a negative control group were set for each amplified gene: crRNA and positive plasmid were added to the experimental group, and crRNA and DEPC-treated water were added to the negative control group. The necessary components were added to the PCR tube, and after ensuring uniform mixing, a real-time fluorescence quantitative PCR instrument was used to react at 37 ° C for 30 minutes. After the reaction was completed, a blue light gel imager was used to observe and record the fluorescence intensity.
[0077] Table 4
[0078]
[0079]
[0080] To test the sensitivity of ERA-CRISPR / Cas12a detection, the standard plasmid was diluted (10-fold gradient, dilution to 1×10 0 ~1×10 6The target fragment was amplified using different amounts of plasmid as template. Each dilution was repeated three times to ensure good repeatability and stability. The decrease in plasmid concentration was associated with a decrease in fluorescence intensity. The minimum detection limit for visual observation under blue light was 1×10 1 Copies. Clinical samples showed that mixed porcine virus infection was common. Using the genomes of multiple porcine pathogens including PRV, PEDV, CSFV, PCV2, and PRRSV as templates, we validated the specificity of the ERA-CRISPR / Cas12a fluorescence method according to the CRISPR-Cas12a fluorescence detection process described above. The results demonstrated the high specificity of the method, as fluorescence was detected only in the presence of ASFV [e.g. Figure 3 As shown, Figure 3 A-3C corresponds to the fluorescence reaction results of the three ASFV genes at different concentrations. Figure 3 A- Figure 3 The concentrations of the eight bands from left to right in C are 1×10 6 copies / μL, 1×10 5 copies / μL, 1×10 4 copies / μL, 1×10 3 copies / μL, 1×10 2 copies / μL, 1×10 1 copies / μL, 1×10 0 copies / μL and negative control (i.e., buffer), where Figure 3 A corresponds to the E183L gene, Figure 3 B corresponds to the K205R gene, Figure 3 C corresponds to the C962R gene; Figure 3 D- Figure 3 F corresponds to the fluorescence reaction results detected by the detection system corresponding to the three genes of ASFV under different virus conditions. Figure 3 D- Figure 3 The viruses corresponding to the 8 bands from left to right in F are the positive control (ASFV), PRV, PPV, PEDV, CSFV, PCV-2, PRRSV, and negative control (buffer). Figure 3 D corresponds to the E183L gene, Figure 3 E corresponds to the K205R gene, Figure 3 F corresponds to C962R gene].
[0081] Verification Example 2: Sensitivity and specificity test of ASFV gene detection using CRISPR / Cas12a lateral flow assay
[0082] To test the sensitivity of the CRISPR / Cas12a lateral flow assay, we performed a 10-fold serial dilution of the standard plasmid pUC57-ASFV gene. The assay can detect plasmids containing the ASFV gene down to 1×10 3 copies. The detection limit of the CRISPR / Cas12a trans-lytic system induced by E183L-crRNA-B, K205R-crRNA-B and C962R-crRNA-A was approximately 1000 copies of ASFV DNA per reaction. In addition, we evaluated the specificity of the CRISPR / Cas12a lateral flow assay for ASFV detection. The specificity of this CRISPR / Cas12a lateral flow assay was particularly demonstrated by cross-reaction tests with other porcine viruses. The DNA of ASFV could be specifically detected without cross-reaction with other viruses (such as Figure 4 As shown, similarly, Figure 4 A-4C corresponds to the colloidal gold reaction results of the three ASFV genes at different concentrations. Figure 4 D- Figure 4 F corresponds to the colloidal gold reaction results of the detection system corresponding to the three genes of ASFV under different virus conditions. It should be noted that Figure 4 The markings here are Figure 3 Correspondingly, Figure 4 Bands 1-8 in A-4C are Figure 3 Bands 1-8 in A-3C correspond one to one, Figure 4 Bands 1-7 in D-4F are Figure 3 Bands 1-7 in A-3C correspond one to one, that is Figure 4 D- Figure 4 F omitted negative control). Specifically, Figure 4 A-4C corresponds to the fluorescence reaction results of the three ASFV genes at different concentrations. Figure 3 A- Figure 3 The concentrations of the eight bands from left to right in C are 1×10 6 copies / μL, 1×10 5 copies / μL, 1×10 4 copies / μL, 1×10 3 copies / μL, 1×10 2 copies / μL, 1×10 1 copies / μL, 1×10 0 copies / μL and negative control (i.e., buffer), where Figure 4 A corresponds to the E183L gene, Figure 4 B corresponds to the K205R gene, Figure 4 C corresponds to the C962R gene; Figure 4 D- Figure 4F corresponds to the fluorescence reaction results detected by the detection system corresponding to the three genes of ASFV under different virus conditions. Figure 4 D- Figure 4 The viruses corresponding to the 7 bands from left to right in F are positive control (ASFV), PRV, PPV, PEDV, CSFV, PCV-2, and PRRSV. Figure 4 D corresponds to the E183L gene, Figure 4 E corresponds to the K205R gene, Figure 4 F corresponds to C962R gene
[0083] The present invention integrates enzymatic recombination isothermal amplification technology with CRISPR / Cas12a technology to perform nucleic acid recognition on the three gene sequences of ASFV E183L, K205R and C962R. The detection is completed within 60 minutes with high specificity and sensitivity. The detection method combines the sensitivity and specificity of CRISPR / Cas12a technology with the visual presentation result readout characteristics of fluorescent or colloidal gold test paper, reducing labor intensity and shortening detection time.
[0084] Verification Example 3: Compliance test of the kit for detecting African swine fever virus nucleic acid using CRISPR-Cas12a fluorescence method
[0085] In order to determine the compliance of this application with the real-time fluorescence RT-PCR method recommended by WOAH, the applicant prepared 30 blind samples, which were tested by other uninformed testers using the two aforementioned methods. The evaluation results are shown in Table 5, which show that the compliance rate is 100%.
[0086] Among them, the specific operation of the real-time fluorescence RT-PCR method recommended by WOAH is as follows:
[0087] Directly use the primers and probes publicly provided and recorded in Chapter 2.8.1 African Swine Fever of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the World Organization for Animal Health (WOAH) (specifically, upstream primer ASF-OIE-rPCRF: 5'-1627-CTGCTCATGGTATCAATCTTATCGA-1651-3'; downstream primer ASF-OIE-rPCRR: 5'-1857-GATACCACAAGATCRGCCGT-1876-3'; fluorescent probe ASF-OIE-Probe: 5'-1761-FAM-CCACGGGAGGAATACCAACCCAGTG-TAMRA-1785-3'), and operate according to the detection procedures and judgment criteria specified in the manual.
[0088] Table 5
[0089]
[0090] The preferred embodiments of the present invention are described in detail above. However, the present invention is not limited to the specific details in the above embodiments. Within the technical concept of the present invention, a variety of simple modifications can be made to the technical solution of the present invention, and these simple modifications all belong to the protection scope of the present invention.
[0091] It should also be noted that the various specific technical features described in the above specific embodiments can be combined in any suitable manner without contradiction. In order to avoid unnecessary repetition, the present invention will not further describe various possible combinations.
[0092] In addition, various embodiments of the present invention may be arbitrarily combined, and as long as they do not violate the concept of the present invention, they should also be regarded as the contents disclosed by the present invention.
Claims
1. A specific crRNA for ASFV detection based on ERA-coupled CRISPR / Cas12a, characterized in that: The specific crRNA for ASFV detection is shown in one or more of SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3, SEQ ID No: 4, SEQ ID No: 5 and SEQ ID No:
6.
2. The specific crRNA for ASFV detection according to claim 1, characterized in that The specific crRNA for ASFV detection is shown in one or more of SEQ ID No: 2, SEQ ID No: 4 and SEQ ID No:
5.
3. An ASFV detection system based on ERA coupled CRISPR / Cas12a, characterized in that: The ASFV detection system includes at least the specific crRNA for ASFV detection as described in claim 1 or 2, an isothermal amplification primer pair that matches the specific crRNA for amplifying the template to be tested, and a ssDNA reporter system.
4. The ASFV detection system according to claim 3, characterized in that The isothermal amplification primer pair is selected from one or more of a first primer pair as shown in SEQ ID No: 7 and SEQ ID No: 8, a second primer pair as shown in SEQ ID No: 9 and SEQ ID No: 10, a third primer pair as shown in SEQ ID No: 11 and SEQ ID No: 12, a fourth primer pair as shown in SEQ ID No: 13 and SEQ ID No: 14, a fifth primer pair as shown in SEQ ID No: 15 and SEQ ID No: 16, and a sixth primer pair as shown in SEQ ID No: 17 and SEQ ID No: 18; Preferably, when containing crRNA as shown in SEQ ID No: 1 and / or SEQ ID No: 2, the first primer pair and / or the second primer pair are used; When containing crRNA as shown in SEQ ID No: 3 and / or SEQ ID No: 4, a third primer pair and / or a fourth primer pair are used; When containing crRNA as shown in SEQ ID No: 5 and / or SEQ ID No: 6, the fifth primer pair and / or the sixth primer pair are used; More preferably, the isothermal amplification primer pair is selected from one or more of the second primer pair, the fourth primer pair and the fifth primer pair.
5. The ASFV detection system according to claim 3 or 4, characterized in that The ssDNA reporter system includes a first ssDNA reporter molecule for fluorescence detection, and / or a second ssDNA reporter molecule for colloidal gold detection; Preferably, the nucleotide sequence of the first ssDNA reporter molecule is: 5'-TTTTTTTT-3', and the nucleotide sequence of the second ssDNA reporter molecule is: 5'-TTTATTT-3'.
6. The ASFV detection system according to claim 5, characterized in that The 5' end of the first ssDNA reporter molecule is modified with a FAM group, and the 3' end is modified with a BHQ1 group; The 5' end of the second ssDNA reporter molecule is modified with a FAM group, and the 3' end is modified with a Biotin group.
7. The ASFV detection system according to claim 3 or 4, characterized in that The ASFV detection system also includes enzymes and buffers required for the ERA process, and the Cas12a enzyme required for the CRISPR / Cas12a system.
8. Use of a specific crRNA for ASFV detection according to claim 1 or 2, or an ASFV detection system according to any one of claims 3-7 in the preparation of an ASFV detection kit.
9. A method for detecting ASFV for non-disease diagnosis purposes, characterized in that: The detection method adopts the ASFV detection system described in any one of claims 3-7.
10. The detection method according to claim 9, characterized in that: The detection method comprises: S100, releasing the nucleic acid in the sample to be tested to obtain a test template, and using isothermal amplification primers to specifically amplify the test template to obtain an amplification product; S200, activating the non-specific single-stranded DNA cleavage activity of the Cas12a enzyme by binding crRNA to the specific gene sequence in the amplified product of step S100; S300, based on the ssDNA reporter system, determine whether the template to be tested contains ASFV by detecting the reporter signal.
Citation Information
Cited By
Portable African swine fever detection method based on ERA-CRISPR / Cas12a technology
CN120775959A
